Join
Live feed
·
PRReleasevia Quantisnow
Definium Therapeutics Inc. logo

Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day

ByQuantisnow·Wall Street's wire, on your screen.
DFTX· Definium Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DFTX (Definium Therapeutics Inc.) and more on Quantisnow.